Table 2.
Foodborne pathogens | Antimicrobial-resistant pathogens | Vaccine-preventable pathogens | ||||||
---|---|---|---|---|---|---|---|---|
L. monocytogenes | S. enterica | Shiga toxin-producing E. coli (STEC) | carbapenemase-producing Enterobacteriaceae (CPE) | AR N. gonorrhoeae | multidrug-resistant (MDR) M. tuberculosis | Human Influenza virus | N. meningitidis | |
Number of countries using WGS-based typing | 13 | 11 | 13 | 9 | 5 | 10 | 12 | 15 |
Typing scheme | ||||||||
First-line | 6 | 3 | 7 | 5 | 5 | 5 | 2 | 6 |
Second-line | 7 | 8 | 6 | 4 | – | 5 | 10 | 9 |
Sampling frame | ||||||||
Continuous comprehensive | 8 | 1 | 6 | 2 | – | 8 | – | 9 |
Sentinel/subset of samples | 4 | 10 | 7 | 7 | 5 | 2 | 12 | 6 |
Bioinformatic analysisa | ||||||||
Core genome multi-locus sequence typing | 10 | 8 | 5 | 5 | 4 | 4 | – | 11 |
Single-nucleotide polymorphism | 7 | 8 | 8 | 4 | 3 | 8 | 4 | 4 |
Resistome prediction | 3 | 6 | 7 | 8 | – | 9 | 10 | 4 |
wgMLST | 2 | 2 | 4 | 3 | 3 | 1 | – | – |
Virulome/mobilome prediction | 1 | 4 | 11 | 4 | 1 | – | – | – |
MLST prediction | 3 | 1 | 2 | – | – | – | – | – |
Serogroup prediction | 3 | 2 | 3 | – | – | – | – | – |
NG-MAST | – | – | – | – | 4 | – | – | – |
Speciation | – | – | – | – | – | 1 | – | – |
Hemagglutinin and neuraminidase sequence prediction | – | – | – | – | – | – | 9 | – |
Phylogenetic relationship | – | – | – | – | – | – | 10 | – |
Identification of specific point mutations | – | – | – | – | – | – | 10 | – |
rMLST | – | – | – | – | – | – | – | 5 |
MLST + porA VR1 and VR2 + fetA | – | – | – | – | – | – | – | 13 |
Vaccine antigens prediction | – | – | – | – | – | – | – | 3 |
Other not specified | – | – | – | – | – | – | – | 2 |
Raw sequence data storage | ||||||||
Dedicated closed database(s) | 11 | 9 | 11 | 8 | 4 | 9 | 9 | 10 |
Publicly available database(s) | 1 | 1 | – | – | – | – | 1 | 3 |
Both dedicated closed database(s) and publicly available database(s) | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 |
aNot mutually exclusive.